Skip to content
Screener

MiMedx Group MDXG Interest Expense

Interest Expense at other companies

IAR
Integra LifeSciencesIART
$22.99M+9.3%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
$427K-62.4%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
-$138K+79.4%
Solventum logo
SolventumSOLV
-$64M+37.9%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$19K-95.4%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$255K-24.1%

Segments

By segment

See full
Reportable Segment$386K-18.7%

Other financials

Income statement

See full
Revenue$64.4M-34.7%
Gross profit$44.4M-44.5%
Operating income-$18.5M-249%
Net income-$14.8M-254%
EPS (diluted)-$0.10-267%

Balance sheet

See full
Cash & equivalents$135.8M+14.3%
Total debt$17.2M-6.8%
Total equity$216.0M-0.3%
Total assets$281.0M-3.5%

Cash flow

See full
Operating cash flow-$10.0M-169%
CapEx$598.0K+234%
Free cash flow-$10.6M-175%

Valuation

See full
Market cap$632.6M-39.3%
Enterprise value$513.97M-45.4%
P/E101.4×+69.0×
P/S1.8×-1.1×

Profitability

See full
Gross margin78.8%-2.6pp
Operating margin2.5%-9.3pp
Net margin1.8%-7.1pp
FCF margin12.5%-3.2pp

Returns & leverage

See full
Return on equity2.9%-13.8pp
Debt / equity0.1×0.0×
Current ratio5.3×+0.9×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001376339-26-000071
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Amortization of intangible assets291100592199
Operating income(18,466)12,370(34,514)20,620
Other expense, net
Interest income, net7887381,6731,244
Other expense, net(102)(101)(270)(247)
(Loss) income before income tax(17,780)13,007(33,111)21,617
Income tax benefit (provision)2,940(3,389)7,411(4,978)
Net (loss) income$(14,840)$9,618$(25,700)$16,639

Item 1. Financial Statements

FAQ

What is MiMedx Group's interest expense?
MiMedx Group (MDXG) reported interest expense of $788K in Q2 2026.
How has MiMedx Group's interest expense changed year-over-year?
MiMedx Group's interest expense increased by 6.8% year-over-year, from $738K to $788K.
What is the long-term trend for MiMedx Group's interest expense?
Over 2 years (2022 to 2025), MiMedx Group's interest expense has grown at a -23.5% compound annual growth rate (CAGR), from -$5.02M to $2.93M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.

Ask your AI about MiMedx Group's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude